Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-05-14

FDA Approved: ELELYSO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for ELELYSO (taliglucerase alfa) filed by Pfizer Laboratories Div Pfizer Inc. The approval results in changes to the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ELELYSO (TALIGLUCERASE ALFA)

Snippet

SUPPL AP for ELELYSO (TALIGLUCERASE ALFA)